Skip to content

Revance Therapeutics, Inc.: filings

Every Revance Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-11-07fiscal Q3 2024501320001479290-24-000128
10-Q2024-08-08fiscal Q2 2024481240001479290-24-000111
10-Q2024-05-09fiscal Q1 202447960001479290-24-000100
10-K2024-02-28fiscal FY 2023541380001479290-24-000038
10-Q2023-11-08fiscal Q3 2023511340001479290-23-000111
10-Q2023-08-08fiscal Q2 2023501300001479290-23-000093
10-Q2023-05-09fiscal Q1 2023511040001479290-23-000072
10-K2023-02-28fiscal FY 2022571440001479290-23-000028
10-Q2022-11-08fiscal Q3 2022521360001479290-22-000102
10-Q2022-08-09fiscal Q2 2022511320001479290-22-000082
10-Q2022-05-10fiscal Q1 2022511040001193125-22-146362
10-K2022-02-28fiscal FY 2021561420001479290-22-000034
10-Q2021-11-09fiscal Q3 2021521380001479290-21-000165
10-Q2021-08-05fiscal Q2 2021501320001479290-21-000150
10-Q2021-05-10fiscal Q1 2021491000001479290-21-000123
10-K2021-02-25fiscal FY 2020501240001479290-21-000057
10-Q2020-11-09fiscal Q3 2020431080001479290-20-000105
10-Q2020-08-06fiscal Q2 2020401030001479290-20-000090
10-Q2020-05-07fiscal Q1 202037770001479290-20-000058
10-K2020-02-26fiscal FY 2019421310001479290-20-000042
10-Q2019-11-04fiscal Q3 201937940001479290-19-000109
10-Q2019-08-06fiscal Q2 201937930001479290-19-000093
10-Q2019-05-09fiscal Q1 201937770001479290-19-000050
10-K2019-02-28fiscal FY 2018391170001479290-19-000030
10-Q2018-11-02fiscal Q3 201833860001479290-18-000108
10-Q2018-08-03fiscal Q2 201831820001479290-18-000101
10-Q2018-05-09fiscal Q1 201831640001479290-18-000067
10-K2018-03-02fiscal FY 2017341020001479290-18-000038
10-Q2017-11-03fiscal Q3 201731800001479290-17-000042
10-Q2017-08-04fiscal Q2 201731800001479290-17-000036
10-Q2017-05-09fiscal Q1 201731620001479290-17-000023
10-K2017-02-28fiscal FY 2016341020001479290-17-000013
10-Q2016-11-04fiscal Q3 2016361020001479290-16-000057
10-Q2016-08-05fiscal Q2 2016351000001479290-16-000049
10-Q2016-05-10fiscal Q1 201634700001479290-16-000039
10-K2016-03-04fiscal FY 2015391410001479290-16-000031
10-Q2015-11-10fiscal Q3 2015351000001479290-15-000010
10-Q2015-08-07fiscal Q2 2015351070001628280-15-006314
10-Q2015-05-14fiscal Q1 201532660001628280-15-004193
10-K2015-03-04fiscal FY 2014371380001628280-15-001461
10-Q2014-11-13fiscal Q3 201432940001193125-14-411349
10-Q2014-08-13fiscal Q2 201433970001193125-14-308616
10-Q2014-05-14fiscal Q1 2014391220001193125-14-199234

Inspect the source

Entity
Revance Therapeutics, Inc. / CIK 0001479290
Captured
2026-09-21T17:20:10.493Z
SEC response SHA-256
076b991a44fc13ae19e1119723bdc78b153314a59cf8c4c1e663921a0cf829cf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001479290.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))